ON
← Back to feed
Boots to begin prescribing medical cannabis in UK
United Kingdom🩺 HealthLean Progressive

Boots to begin prescribing medical cannabis in UK

Boots has announced it will become the first UK high-street pharmacy to prescribe medical cannabis through its new online service, SureLeaf. The service targets adults over 25 suffering from eligible conditions such as chronic pain, anxiety, or insomnia, requiring patients to first fail conventional treatments. To ensure safety, prescriptions undergo independent review by a multidisciplinary clinical team including a second consultant, and the initiative includes a collaborative research program with the University of Nottingham to study patient outcomes. The move follows the 2018 legalization of cannabis-derived medicines in the UK, which was prompted by a high-profile case involving a child with severe epilepsy. While the National Health Service currently restricts access to specific conditions like rare epilepsies and chemotherapy side effects, private clinics have increasingly used these drugs for broader psychiatric and neurological issues.

Go to the primary sources (1)

The official sources this coverage is built on. Read them directly to bypass framing.

3 reports

Daily Express logoDaily ExpressIndependentCenter
Boots to become first UK pharmacy to prescribe cannabis

Boots, a major UK pharmacy chain, will become the first in the country to privately prescribe cannabis to patients with specific conditions such as insomnia, chronic pain, and generalized anxiety. Patients must first attempt traditional treatments and undergo screening for conditions like psychosis before being eligible for the prescription. The cannabis will be provided through Boots' online doctor service, Sureleaf, requiring a video consultation. The move follows Boots' acquisition by a Canadian firm, which has experience with medical cannabis legalization. The initiative emphasizes clinical oversight and individualized assessments to ensure safe and effective treatment.

Bias read (Center): The article presents factual information about Boots' new service without overtly favoring either side, using neutral language and citing official statements from Boots representatives.

The Sun logoThe SunIndependentProgressive
Boots to become first UK high street pharmacy to privately prescribe CANNABIS to patients

Boots has introduced a new online service called SureLeaf, making it the first major UK high-street pharmacy chain to offer private prescriptions for medicinal cannabis. The initiative allows eligible patients to access the Class B controlled substance through the Boots Online Doctor platform. This move aims to provide treatment options for various medical conditions via a direct-to-consumer model rather than solely through traditional National Health Service channels.

Bias read (Progressive): The framing emphasizes accessibility and patient empowerment by highlighting 'trusted' retail status and private provision, implicitly contrasting favorablely against potential bureaucratic hurdles of public healthcare systems.

The Guardian (UK) logoThe Guardian (UK)IndependentCenter
Boots to begin prescribing medical cannabis in UK

Boots has announced it will become the first UK high-street pharmacy to prescribe medical cannabis through its new online service, SureLeaf. The service targets adults over 25 suffering from eligible conditions such as chronic pain, anxiety, or insomnia, requiring patients to first fail conventional treatments. To ensure safety, prescriptions undergo independent review by a multidisciplinary clinical team including a second consultant, and the initiative includes a collaborative research program with the University of Nottingham to study patient outcomes. The move follows the 2018 legalization of cannabis-derived medicines in the UK, which was prompted by a high-profile case involving a child with severe epilepsy. While the National Health Service currently restricts access to specific conditions like rare epilepsies and chemotherapy side effects, private clinics have increasingly used these drugs for broader psychiatric and neurological issues.

Bias read (Center): The article maintains a neutral tone by balancing corporate promotional quotes with objective historical context regarding the 2018 legalization and current NHS restrictions.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories